As of 2025-03-21, the EV/EBITDA ratio of Harpoon Therapeutics Inc (HARP) is -18.12. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HARP's latest enterprise value is 483.51 mil USD. HARP's TTM EBITDA according to its financial statements is -26.68 mil USD. Dividing these 2 quantities gives us the above HARP EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.9x - 12.1x | 10.0x |
| Forward P/E multiples | 10.7x - 21.7x | 16.2x |
| Fair Price | (12.92) - (14.67) | (15.92) |
| Upside | -156.2% - -163.8% | -169.2% |
| Date | EV/EBITDA |